ALKERMES | ALKS - Reddito Netto

Prezzo Delle Azioni
33.59
Cambio Giornaliero
-0.13 -0.37%
Mensile
-3.60%
Annuale
5.68%
Q2 Previsione
32.32




Reddito Netto Cambiamento Data
AbbVie USD 695M 1.12B 2026-03
Acadia Pharmaceuticals USD 273.57M 201.79M 2025-12
ALKERMES USD 49.34M 33.42M 2025-12
Amgen USD 1.82B 486M 2026-03
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD -46.57M 15.83M 2025-12
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Coherus Biosciences USD -37.64M 2.11M 2025-12
Eli Lilly USD 7.4B 760M 2026-03
Gilead Sciences USD 2.18B 869M 2025-12
Heron Therapeutics USD -2.95M 14.54M 2025-12
Ionis Pharmaceuticals USD -93M 136M 2026-03
J&J USD 5.24B 119M 2026-03
Malin Corporation EUR -1.1M 2.2M 2023-12
Merck USD -4.24B 7.2B 2026-03
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Nektar Therapeutics USD -36.08M 978K 2025-12
Neurocrine Biosciences USD 209.5M 102M 2025-09
Otsuka Holdings JPY 98.35B 32.86B 2026-03
Ovoca Bio EUR -765K 4.89M 2025-06
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 727.2M 117.4M 2026-03
Vertex Pharmaceuticals USD 1.19B 108.2M 2025-12